Andrew Tobin and Graeme Milligan have long-standing research programmes surrounding the muscarinic G protein-coupled receptor (GPCR) family and its links to neurodegeneration.

The M4 programme at Keltic and selective activators of the M4 muscarinic receptor.

Learn more about Keltic Pharma Therapeutics

We are happy to an answer questions about our company, malaria, drug discovery platform technology and partnering opportunities.